The fifth Risperdal case to go to trial was a game changer for Janssen Pharmaceuticals and its parent company, Johnson & Johnson (J&J). The companies previously escaped large payouts...
When Johnson & Johnson (J&J) and its subsidiary Janssen Pharmaceuticals received FDA approval for their antipsychotic Risperdal in 1993, the companies anticipated the drug would be a blockbuster hit....
With more than 9,000 Xarelto lawsuits currently pending in three different venues, the first MDL bellwether trials in Louisiana will be pivotal. After a heated debate, the first four...
Healthcare giant Johnson & Johnson (J&J) and its subsidiary Janssen Pharmaceuticals were likely shocked by the $70 million plaintiff’s verdict after the fifth Risperdal trial this past July. The...
For thousands of Risperdal lawsuits pending in Philadelphia, a judges ruling could see their cases dismissed. A Pennsylvania appeals court has heard arguments from both sides regarding when the...
Although two bellwether cases for the Xarelto litigation have been postponed by one month, the litigation is still traveling full speed ahead. Manufacturers Janssen Pharmaceuticals (a subsidiary of Johnson...
Plaintiffs in the Xarelto litigation have waited for some time to face drug manufacturers in court, but they will have to wait just a little longer. The U.S. District...
One of the strongest pieces of evidence presented in the Risperdal trials is a video deposition of former FDA Commissioner David Kessler testifying that Janssen and J&J manipulated clinical...
As Janssen Pharmaceuticals and Bayer A.G. face more than 7,000 Xarelto lawsuits, a new study was published that will likely add to the company’s fears. A study published in...
With more than 7,000 lawsuits currently pending against Xarelto manufacturers, the litigation is reaching a fever pitch. Because of an increase in filings, plaintiffs were recently given an additional...
